Skip to main content

Articles

Page 60 of 154

  1. Glomerulonephritis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Deposition of autoantibodies in the glomeruli plays a key role in the development of lupus ne...

    Authors: Jessica J Manson, Alexander Ma, Pauline Rogers, Lesley J Mason, Jo H Berden, Johan van der Vlag, David P D'Cruz, David A Isenberg and Anisur Rahman
    Citation: Arthritis Research & Therapy 2009 11:R154
  2. The past 10 years have seen the description of families of receptors that drive proinflammatory cytokine production in infection and tissue injury. Two major classes have been examined in the context of inflam...

    Authors: William J McCormack, Andrew E Parker and Luke A O'Neill
    Citation: Arthritis Research & Therapy 2009 11:243
  3. Advances in genetics and new understanding of the molecular pathways that mediate innate and adaptive immune system activation, along with renewed focus on the role of the complement system as a mediator of in...

    Authors: Mary K Crow
    Citation: Arthritis Research & Therapy 2009 11:245
  4. B-cell development is tightly regulated, including the induction of B-cell memory and antibody-secreting plasmablasts and plasma cells. In the last decade, we have expanded our understanding of effector functi...

    Authors: Thomas Dörner, Annett M Jacobi and Peter E Lipsky
    Citation: Arthritis Research & Therapy 2009 11:247
  5. Many of the chronic inflammatory and degenerative disorders that present to clinical rheumatologists have a complex genetic aetiology. Over the past decade a dramatic improvement in technology and methodology ...

    Authors: Alex Clarke and Timothy J Vyse
    Citation: Arthritis Research & Therapy 2009 11:248
  6. Undifferentiated arthritis (UA) has a variable disease course; 40 to 50% of UA patients remit spontaneously, while 30% develop rheumatoid arthritis (RA). Identifying the UA patients who will develop RA is esse...

    Authors: Mohamed M Thabet, Thomas WJ Huizinga, Désirée M van der Heijde and Annette HM van der Helm-van Mil
    Citation: Arthritis Research & Therapy 2009 11:R155
  7. Cell stimulation leads to the shedding of phosphatidylserine (PS)-rich microparticles (MPs). Because autoimmune diseases (AIDs) are characterized by cell activation, we investigated level of circulating MPs as...

    Authors: Jérémie Sellam, Valérie Proulle, Astrid Jüngel, Marc Ittah, Corinne Miceli Richard, Jacques-Eric Gottenberg, Florence Toti, Joelle Benessiano, Steffen Gay, Jean-Marie Freyssinet and Xavier Mariette
    Citation: Arthritis Research & Therapy 2009 11:R156
  8. The aim of this study was to determine a low disease activity threshold - a 28-joint disease activity score (DAS28) value - for the decision to maintain unchanged disease-modifying antirheumatic drug (DMARD) t...

    Authors: Michel de Bandt, Bruno Fautrel, Jean Francis Maillefert, Jean Marie Berthelot, Bernard Combe, René-Marc Flipo, Frédéric Lioté, Olivier Meyer, Alain Saraux, Daniel Wendling, Xavier Le Loët and Francis Guillemin
    Citation: Arthritis Research & Therapy 2009 11:R157
  9. Interleukin (IL)-17 plays an important role in the pathogenesis of rheumatoid arthritis and the mouse model collagen-induced arthritis (CIA). Interferon(IFN)-γ and IL-4 have been shown to suppress Th17 develop...

    Authors: Sujata Sarkar, Laura A Cooney, Peter White, Deborah B Dunlop, Judith Endres, Julie M Jorns, Matthew J Wasco and David A Fox
    Citation: Arthritis Research & Therapy 2009 11:R158
  10. Calcified deposits (CDs) in skin and muscles are common in juvenile dermatomyositis (DM), and less frequent in adult DM. Limited information exists about the microstructure and composition of these deposits, a...

    Authors: Naomi Eidelman, Alan Boyde, Andrew J Bushby, Peter GT Howell, Jirun Sun, Dale E Newbury, Frederick W Miller, Pamela G Robey and Lisa G Rider
    Citation: Arthritis Research & Therapy 2009 11:R159
  11. The majority of autoimmune diseases predominate in females. In searching for an explanation for this female excess, most attention has focused on hormonal changes - both exogenous changes (for example, oral co...

    Authors: Jacqueline E Oliver and Alan J Silman
    Citation: Arthritis Research & Therapy 2009 11:252
  12. The field of biomarkers is a growing one, particularly in osteoarthritis (OA). OA is the most common disabling condition in older persons and a major cause of morbidity. While the debate continues about which ...

    Authors: Frances MK Williams
    Citation: Arthritis Research & Therapy 2009 11:130
  13. Despite recent advances in anti-inflammatory therapy, rheumatoid arthritis (RA) patients continue to rate pain as a priority. The etiology of RA pain is likely multifactorial, including both inflammatory and n...

    Authors: Yvonne C Lee, Lori B Chibnik, Bing Lu, Ajay D Wasan, Robert R Edwards, Anne H Fossel, Simon M Helfgott, Daniel H Solomon, Daniel J Clauw and Elizabeth W Karlson
    Citation: Arthritis Research & Therapy 2009 11:R160
  14. The role of adiponectin in the pathogenesis of arthritis is still controversial. This study was performed to examine whether adiponectin is involved in joint inflammation and destruction in rheumatoid arthriti...

    Authors: Hyun-Mi Choi, Yeon-Ah Lee, Sang-Hoon Lee, Seung-Jae Hong, Dae-Hyun Hahm, Sang-Yun Choi, Hyung-In Yang, Myung Chul Yoo and Kyoung Soo Kim
    Citation: Arthritis Research & Therapy 2009 11:R161
  15. To determine if structural bone parameters obtained from dual energy X-ray absorptiometry (DXA) contribute to the prediction of progression of hip osteoarthritis (OA) and to test if the difference between the ...

    Authors: Martha C Castaño Betancourt, Jacqueline C Van der Linden, Fernando Rivadeneira, Rianne M Rozendaal, Sita M Bierma Zeinstra, Harrie Weinans and Jan H Waarsing
    Citation: Arthritis Research & Therapy 2009 11:R162
  16. The aim of our analysis was to compare the gaining of a major response (disease activity score [DAS] remission or American College of Rheumatology 70% improvement criteria [ACR70]) by switching between all the...

    Authors: Stefano Alivernini, Antonella Laria, Elisa Gremese, Angelo Zoli and Gianfranco Ferraccioli
    Citation: Arthritis Research & Therapy 2009 11:R163
  17. In 2008, the Food and Drugs Administration required manufacturers of TNFα antagonists to strengthen their warnings about the risk of serious fungal infections in patients with rheumatoid arthritis (RA). Sinus ...

    Authors: Ariane Leboime, Jean-Marie Berthelot, Yannick Allanore, Lama Khalil-Kallouche, Philippe Herman, Philippe Orcel and Frédéric Lioté
    Citation: Arthritis Research & Therapy 2009 11:R164
  18. Currently available treatments for osteoarthritis (OA) are restricted to nonsteroidal anti-inflammatory drugs, which exhibit numerous side effects and are only temporarily effective. Thus novel, safe and more ...

    Authors: Constanze Csaki, Ali Mobasheri and Mehdi Shakibaei
    Citation: Arthritis Research & Therapy 2009 11:R165
  19. The etiology of degenerative disc disease is unknown. Several investigators have reported the presence of proteolytic enzymes, such as the matrix metalloproteinase (MMP) and ADAMTS (a disintegrin and metallopr...

    Authors: Shoji Seki, Yumiko Asanuma-Abe, Koichi Masuda, Yoshiharu Kawaguchi, Kunihiro Asanuma, Carol Muehleman, Akiko Iwai and Tomoatsu Kimura
    Citation: Arthritis Research & Therapy 2009 11:R166
  20. Immunosuppressants, including anti-TNFα antibodies, have remarkable effects in rheumatoid arthritis; however, they increase infectious events. The present study was designed to examine the effects and immunolo...

    Authors: Keiichi Iwanami, Isao Matsumoto, Yohei Yoshiga, Asuka Inoue, Yuya Kondo, Kayo Yamamoto, Yoko Tanaka, Reiko Minami, Taichi Hayashi, Daisuke Goto, Satoshi Ito, Yasuharu Nishimura and Takayuki Sumida
    Citation: Arthritis Research & Therapy 2009 11:R167
  21. Axial spondyloarthropathy (SpA) is a group of inflammatory diseases, with ankylosing spondylitis as the prototype. SpA affects the axial skeleton, entheses, joints and, at times, the eyes. This study tested th...

    Authors: Srilakshmi M Sharma, Dongseok Choi, Stephen R Planck, Christina A Harrington, Carrie R Austin, Jinnell A Lewis, Tessa N Diebel, Tammy M Martin, Justine R Smith and James T Rosenbaum
    Citation: Arthritis Research & Therapy 2009 11:R168
  22. Spontaneous resorption of disc herniation (DH) after sciatica is well documented. The matrix metalloproteinases (MMP)-1 and MMP-3 are enzymes potentially involved in this process. Glucocorticoid injections are...

    Authors: Stéphane Genevay, Axel Finckh, Françoise Mezin, Enrico Tessitore and Pierre-André Guerne
    Citation: Arthritis Research & Therapy 2009 11:R169
  23. The objective of this study was to assess the impact of certolizumab pegol (CZP) treatment on health-related quality of life (HRQoL), fatigue and other patient-reported outcomes (PROs) in patients with rheumat...

    Authors: Vibeke Strand, Philip Mease, Gerd R Burmester, Enkeleida Nikaï, Geoffroy Coteur, Ronald van Vollenhoven, Bernard Combe, Edward C Keystone and Arthur Kavanaugh
    Citation: Arthritis Research & Therapy 2009 11:R170
  24. Ankylosing spondylitis (AS) is a severe, chronic inflammatory disease strongly associated with HLA-B27. The presence of additional HLA risk factors has been suggested by several studies. The aim of the current...

    Authors: Fabiana Paladini, Francesca Belfiore, Elisa Cocco, Carlo Carcassi, Alberto Cauli, Alessandra Vacca, Maria Teresa Fiorillo, Alessandro Mathieu, Isabella Cascino and Rosa Sorrentino
    Citation: Arthritis Research & Therapy 2009 11:R171
  25. Earlier work indicates that the cholesterol-lowering drug, simvastatin, is anabolic to chondrogenic expression of rat intervertebral disc (IVD) cells, which suggests a potential role for simvastatin in IVD reg...

    Authors: Huina Zhang, Lin Wang, Jun Beom Park, Paul Park, Victor C Yang, Scott J Hollister, Frank La Marca and Chia-Ying Lin
    Citation: Arthritis Research & Therapy 2009 11:R172
  26. Renal involvement is common in systemic lupus erythematosus. Early diagnosis of lupus nephritis (LN), allowing the instigation of appropriate therapy, remains an important clinical challenge. Current biomarker...

    Authors: Neeraj Dhaun and David C Kluth
    Citation: Arthritis Research & Therapy 2009 11:133
  27. Little is known about endogenous or cytokine-stimulated aggrecan catabolism in the meniscal fibrocartilage of the knee. The objectives of this study were to characterize the structure, distribution, and proces...

    Authors: Christopher G Wilson, Eric J Vanderploeg, Fengrong Zuo, John D Sandy and Marc E Levenston
    Citation: Arthritis Research & Therapy 2009 11:R173
  28. A protein analysis using a mass spectrometry indicated that there are serum proteins showing significant quantitative changes after the administration of infliximab. Among them, connective tissue growth factor...

    Authors: Kazuhisa Nozawa, Maki Fujishiro, Mikiko Kawasaki, Hiroshi Kaneko, Kazuhisa Iwabuchi, Mitsuaki Yanagida, Fujihiko Suzuki, Keiji Miyazawa, Yoshinari Takasaki, Hideoki Ogawa, Kenji Takamori and Iwao Sekigawa
    Citation: Arthritis Research & Therapy 2009 11:R174
  29. One of the major challenges in rheumatology is to overcome the classification criteria that previously defined systemic lupus erythematosis, since the heterogeneity of the disease(s) appears to represent a com...

    Authors: Michael F Smith Jr, Falk Hiepe, Thomas Dörner and Gerd Burmester
    Citation: Arthritis Research & Therapy 2009 11:255
  30. Polymerase chain reaction (PCR) and ligase chain reaction (LCR) are used in research for detection of Chlamydia trachomatis (C. tr.) in synovial fluid (SF). However there is no standardized system for diagnost...

    Authors: Julia Freise, Iris Bernau, Sabine Meier, Henning Zeidler and Jens G Kuipers
    Citation: Arthritis Research & Therapy 2009 11:R175
  31. Co-stimulatory signal B7(CD80/CD86):CD28 is needed in order to activate T cells in immune response. Cytotoxic T lymphocyte-associated antigen-4-immunoglobulin (CTLA4-Ig) binding to the B7 molecules on antigen-...

    Authors: Maurizio Cutolo, Stefano Soldano, Paola Montagna, Alberto Sulli, Bruno Seriolo, Barbara Villaggio, Pierfranco Triolo, Paolo Clerico, Lamberto Felli and Renata Brizzolara
    Citation: Arthritis Research & Therapy 2009 11:R176
  32. Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) share similarities and are classified as spondyloarthropathies. In IBD, anti-Saccharomyces cerevisiae antibody (ASCA), anti-I2 (associated with ant...

    Authors: Matthew L Mundwiler, Ling Mei, Carol J Landers, John D Reveille, Stephan Targan and Michael H Weisman
    Citation: Arthritis Research & Therapy 2009 11:R177
  33. Synovial biopsies, gained either by blind needle biopsy or minimally invasive arthroscopy, offer additional information in certain clinical situations where routine assessment has not permitted a certain diagn...

    Authors: Stefan Vordenbäumen, Leo AB Joosten, Johannes Friemann, Matthias Schneider and Benedikt Ostendorf
    Citation: Arthritis Research & Therapy 2009 11:256
  34. Treatment with the chimerical monoclonal antibody rituximab results in CD20-directed B cell depletion. Although this depletion is almost complete in the peripheral blood of nearly all patients with rheumatoid ...

    Authors: Maria JH Boumans and Paul P Tak
    Citation: Arthritis Research & Therapy 2009 11:134
  35. Adjustment of infliximab dosage for individuals may be useful in improving therapeutic response in rheumatoid arthritis (RA). Herein, we aimed to determine whether measurement of infliximab serum concentration...

    Authors: Denis Mulleman, Jean-Camille Méric, Gilles Paintaud, Emilie Ducourau, Charlotte Magdelaine-Beuzelin, Jean-Pierre Valat and Philippe Goupille
    Citation: Arthritis Research & Therapy 2009 11:R178
  36. Reactivation of hepatitis B virus (HBV) infection in patients with past infection has been described in 5% to 10% of individuals undergoing immunosuppressive therapies. No data are available to date on the out...

    Authors: Caroline Charpin, Sandrine Guis, Philippe Colson, Patrick Borentain, Jean-Pierre Mattéi, Patrice Alcaraz, Nathalie Balandraud, Benoit Thomachot, Jean Roudier and René Gérolami
    Citation: Arthritis Research & Therapy 2009 11:R179
  37. Chicken type II collagen (CCII) is a protein extracted from the cartilage of chicken breast and exhibits intriguing possibilities for the treatment of autoimmune diseases by inducing oral tolerance. A 24-week,...

    Authors: Wei Wei, Ling-Ling Zhang, Jian-Hua Xu, Feng Xiao, Chun-De Bao, Li-Qing Ni, Xing-Fu Li, Yu-Qing Wu, Ling-Yun Sun, Rong-Hua Zhang, Bao-Liang Sun, Sheng-Qian Xu, Shang Liu, Wei Zhang, Jie Shen, Hua-Xiang Liu…
    Citation: Arthritis Research & Therapy 2009 11:R180
  38. Given the emerging evidence that osteoarthritis (OA) may have a vascular basis, the aim of this study was to determine whether serum lipids were associated with change in knee cartilage, presence of bone marro...

    Authors: Miranda L Davies-Tuck, Fahad Hanna, Susan R Davis, Robin J Bell, Sonia L Davison, Anita E Wluka, Jenny Adams and Flavia M Cicuttini
    Citation: Arthritis Research & Therapy 2009 11:R181
  39. Functional status is an integral component of health-related quality of life in patients with ankylosing spondylitis (AS). The purpose of this study was to investigate the role of psychological variables in se...

    Authors: Tamar F Brionez, Shervin Assassi, John D Reveille, Thomas J Learch, Laura Diekman, Michael M Ward, John C Davis Jr, Michael H Weisman and Perry Nicassio
    Citation: Arthritis Research & Therapy 2009 11:R182

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions